New Insights of CTLA-4 into Its Biological Function in Breast Cancer

E-ISSN： 1873-5576|10|7|728-736

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.7, 2010-11, pp. : 728-736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast cancer in Wilms tumor survivors: New insights into primary and secondary prevention

Cancer, Vol. 120, Iss. 23, 2014-12 ,pp. : 3598-3601

Blackwell Publishing

Access to resources Recommend Favorite

Design, Synthesis and Biological Evaluation of 4-(Imidazolylmethyl)-2- Aryl-Quinoline Derivatives as Aromatase Inhibitors and Anti-breast Cancer Agents

Letters in Drug Design & Discovery, Vol. 13, Iss. 1, 2015-10 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

New drugs in breast cancer

By Miller William R Iqbal Shabana

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 975-985

Informa Healthcare

Access to resources Recommend Favorite

Colon Cancer: The New Breast Cancer

By Burstein Harold J.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 8, 2009-09 ,pp. : 773-773

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New insights into the biological therapy of Crohn’s disease

By Hassan Cesare Zullo Angelo Campo Salvatore MA Morini Sergio

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. : 409-419

Informa Healthcare

Access to resources Recommend Favorite